Evidence map›Paper›PMID 18548141›Full record

ReviewThe Canadian journal of cardiology2008

The 2008 Canadian Hypertension Education Program recommendations: the scientific summary -- an annual update.

Canadian Hypertension Education Program

Abstract readReview
In one paragraph

Review in The Canadian journal of cardiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Can gestational hypertension be modified by treating nocturnal airflow limitation?Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2013
    Trial
  2. Article
  3. Article
  4. Article
  5. 2009 Canadian Hypertension Education Program recommendations: an annual update.Canadian family physician Medecin de famille canadien · 2009
    Article
  6. Hypertension in diabetes: a call to action.The Canadian journal of cardiology · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Canadian Hypertension Education ProgramDepartment of Medicine, Community Health Sciences, and Pharmacology and Therapeutics, University of Calgary, Libin Cardiovascular Institute of Alberta, Alberta.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present paper summarizes and highlights key messages of the 2008 Canadian Hypertension Education Program recommendations for the diagnosis and management of hypertension. The 2008 recommendations emphasize proper self-measurement of blood pressure as a step toward greater patient involvement in hypertension management. Home measurement is a better predictor of cardiovascular events than office measures; it can also confirm the diagnosis of hypertension, improve blood pressure control, reduce the need for medications in some patients, screen for white coat and masked hypertension, and improve medication adherence in nonadherent patients. The recommendations continue to emphasize the importance of reducing dietary sodium and implementing other lifestyle changes to prevent and control hypertension. Furthermore, regular assessment of blood pressure at all appropriate visits and identification and management of all cardiovascular risk factures continue to be the cornerstone of the Canadian Hypertension Education Program. Most of the new evidence in 2008 confirmed previous Canadian Hypertension Education Program recommendations. A notable new recommendation is the option to initiate pharmacotherapy with two first therapies if blood pressure is higher than 20/10 mmHg above target. Recently, the Ontario Blood Pressure survey found the treatment and control rate of hypertension in Ontario to be far higher than anywhere else in the world. This speaks to the success of primary care and the Canadian health system in diagnosing, treating and controlling hypertension.

Indexed as

Practice Guidelines as TopicAntihypertensive AgentsCanadaClinical CompetenceEducation, Medical, ContinuingHumansHypertensionProgram EvaluationAntihypertensive Agents

Identifiers

PMID18548141
PMCPMC2643188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.